Found 14 matching trials
Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum N/A The purpose of this study was to evaluate the pharmacokinetic (PK) properti...
Show More Learn More & Join Trial
Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in Children With MDR-TB With and Without HIV PHASE1 This Phase I/II study evaluated the pharmacokinetics, safety, and tolerabil...
Show More Location
Byramjee Jeejeebhoy Medical College (BJMC) CRS
Learn More & Join Trial
A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683 PHASE2 A phase 2, multicenter, uncontrolled, open-label trial in participants with...
Show More Location
Beijing Chest Hospital
Learn More & Join Trial
Short-course Regimens for the Treatment of Pulmonary Tuberculosis PHASE2 The purpose of this study is to determine whether one or two 17-week regime...
Show More Status
Active Not Recruiting
Location
TBTC Site 26 Seattle & King County TB Control Program
Learn More & Join Trial
Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry) N/A This study is to evaluate the effectiveness and safety of a 9-month MDR-END...
Show More Location
Multiple Locations
Learn More & Join Trial
Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis PHASE1 The purpose of this trial is to determine the pediatric dose of delamanid t...
Show More Location
De La Salle Health Sciences Institute
Learn More & Join Trial
Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis PHASE2 This study measured the early bactericidal activity (EBA), safety, tolerabi...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis PHASE2 The purpose of this study is:
* To evaluate the safety and tolerability of...
Show More Location
Infectology Center of Latvia - Clinic of Tuberculosis and Lung Diseases
Learn More & Join Trial
A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB) PHASE2 The purpose of this trial is to assess the safety, tolerability, pharmacoki...
Show More Location
De La Salle Health Sciences Institute
Learn More & Join Trial
A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets PHASE2 This is a multicenter, randomized, open-label, active-controlled clinical s...
Show More Location
Wuhan Pulmonary Hospital
Learn More & Join Trial